ReviewCureus2025

Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).

Fabeha Zafar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.